|

PCI 24781 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Abexinostat

Pipeline

Phase 1: 1

Top Sponsors

  • University of Nebraska1

Indications

  • Gliosarcoma1
  • Anaplastic Astrocytoma1
  • Recurrent High Grade Glioma1
  • Anaplastic Oligodendroglioma1
  • Glioblastoma1

Omaha, Nebraska1 trial

A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma

University of Nebraska Medical Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.